X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35933) 35933
Publication (2948) 2948
Newsletter (1340) 1340
Newspaper Article (815) 815
Government Document (447) 447
Book Review (268) 268
Book Chapter (186) 186
Magazine Article (82) 82
Book / eBook (71) 71
Conference Proceeding (63) 63
Report (61) 61
Transcript (29) 29
Trade Publication Article (28) 28
Dissertation (26) 26
Web Resource (17) 17
Data Set (8) 8
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (15647) 15647
humans (15461) 15461
index medicus (14699) 14699
phosphates (14168) 14168
male (12247) 12247
female (8883) 8883
rats (6664) 6664
analysis (4649) 4649
mice (4470) 4470
middle aged (4060) 4060
pharmacology & pharmacy (4037) 4037
adult (4002) 4002
phosphate (3236) 3236
aged (2829) 2829
research (2612) 2612
biochemistry & molecular biology (2587) 2587
phosphates - blood (2398) 2398
phosphates - metabolism (2239) 2239
physiological aspects (2191) 2191
time factors (2152) 2152
metabolism (2015) 2015
endocrinology & metabolism (1991) 1991
proteins (1906) 1906
neurosciences (1895) 1895
calcium (1887) 1887
dose-response relationship, drug (1814) 1814
health aspects (1791) 1791
urology & nephrology (1774) 1774
in-vitro (1772) 1772
phosphates - administration & dosage (1766) 1766
rats, sprague-dawley (1757) 1757
enzymes (1749) 1749
article (1694) 1694
calcium - blood (1689) 1689
cell biology (1683) 1683
cancer (1675) 1675
rats, wistar (1536) 1536
expression (1491) 1491
glucose (1468) 1468
treatment outcome (1464) 1464
oxidative stress (1463) 1463
medicine (1436) 1436
drugs (1434) 1434
care and treatment (1431) 1431
disease models, animal (1418) 1418
cells (1397) 1397
calcium phosphate (1365) 1365
research article (1349) 1349
hydrogen-ion concentration (1323) 1323
administration, oral (1319) 1319
materials science, biomaterials (1301) 1301
calcium - metabolism (1281) 1281
adolescent (1274) 1274
cells, cultured (1256) 1256
drug delivery systems (1256) 1256
toxicology (1241) 1241
gene expression (1232) 1232
medicine, research & experimental (1232) 1232
oncology (1230) 1230
calcium phosphates (1196) 1196
engineering, biomedical (1186) 1186
phosphorus (1150) 1150
kinetics (1141) 1141
physiology (1131) 1131
inflammation (1111) 1111
in-vivo (1108) 1108
multidisciplinary sciences (1108) 1108
nanoparticles (1077) 1077
rodents (1071) 1071
apoptosis (1063) 1063
diet (1062) 1062
child (1030) 1030
immunology (1030) 1030
mice, inbred c57bl (1028) 1028
rabbits (1025) 1025
liver (1019) 1019
surgery (1019) 1019
medicine & public health (1008) 1008
parathyroid hormone - blood (942) 942
science (942) 942
chemistry (923) 923
brain (915) 915
therapy (913) 913
dextrose (911) 911
medical research (910) 910
hydroxyapatite (906) 906
bone (901) 901
risk factors (886) 886
in vitro techniques (880) 880
studies (845) 845
inhibition (836) 836
liver - metabolism (830) 830
parathyroid hormone (825) 825
metabolites (824) 824
activation (822) 822
diabetes (817) 817
nutrition & dietetics (814) 814
dogs (812) 812
growth (810) 810
biochemistry (804) 804
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Engineering & Comp. Sci. - Stacks (6) 6
UTL at Downsview - May be requested (6) 6
Earth Sciences (Noranda) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37824) 37824
German (349) 349
French (181) 181
Russian (144) 144
Japanese (116) 116
Spanish (67) 67
Chinese (52) 52
Polish (45) 45
Italian (42) 42
Portuguese (16) 16
Czech (14) 14
Hungarian (14) 14
Korean (12) 12
Danish (10) 10
Dutch (10) 10
Swedish (5) 5
Lithuanian (4) 4
Norwegian (4) 4
Romanian (4) 4
Ukrainian (4) 4
Bulgarian (3) 3
Slovak (3) 3
Turkish (3) 3
Finnish (2) 2
Serbian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9739, pp. 431 - 439
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2017, Volume 70, Issue 12, pp. 1479 - 1492
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9548, pp. 1696 - 1705
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and suppresses glucagon secretion, inhibits gastric emptying, and... 
MEDICINE, GENERAL & INTERNAL | IN-VITRO | METFORMIN-TREATED PATIENTS | HEALTHY-SUBJECTS | 2ND-PHASE INSULIN-SECRETION | IMPROVES GLYCEMIC CONTROL | BETA-CELL APOPTOSIS | IV INHIBITOR | 7-36 AMIDE | IMPROVED GLUCOSE-TOLERANCE | EXENATIDE SYNTHETIC EXENDIN-4 | Triazoles - administration & dosage | Triazoles - adverse effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Pyrazines - administration & dosage | Glucagon-Like Peptide 1 - biosynthesis | Dipeptidyl Peptidase 4 | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Adenosine Deaminase Inhibitors | Peptides - administration & dosage | Hypoglycemic Agents - administration & dosage | Adamantane - therapeutic use | Pyrrolidines | Venoms - administration & dosage | Nitriles | Sitagliptin Phosphate | Adamantane - administration & dosage | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Glucagon-Like Peptide 1 - classification | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Drug Administration Schedule | Glucagon-Like Peptide 1 - analogs & derivatives | Venoms - adverse effects | Glycoproteins - antagonists & inhibitors | Clinical Trials as Topic | Glucagon-Like Peptide-1 Receptor | Dipeptidyl-Peptidase IV Inhibitors | Pyrazines - adverse effects | Venoms - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Peptides - adverse effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Type 2 diabetes | Care and treatment | Diagnosis | Glucagon | Analysis | Dosage and administration | Research | Protease inhibitors | Drug therapy | Proteins | Diabetes | Kinases | Insulin | Rodents
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 06/2012, Volume 81, Issue 2, pp. 248 - 256
Schematic illustration of drug-loaded folic acid targeted nanoparticles of mixed lipid-shell and PLGA core (FLPNPs). A functional drug carrier comprised of... 
Drug delivery | PLGA | Nanoparticle | Paclitaxel | GYNECOLOGIC-ONCOLOGY-GROUP | BIODEGRADABLE MICROSPHERES | DRUG-DELIVERY | CONTROLLED-RELEASE | PHASE-II | LIPOSOMAL DAUNORUBICIN | CANCER | RECURRENT | ENDOTHELIAL-CELLS | METASTATIC NASOPHARYNGEAL CARCINOMA | PHARMACOLOGY & PHARMACY | Polymers - administration & dosage | Nanoparticles - chemistry | Humans | Drug Carriers - administration & dosage | Polyethylene Glycols - chemistry | Drug Carriers - chemistry | Tissue Distribution | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Lipids - chemistry | Female | Paclitaxel - administration & dosage | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Lactic Acid - chemistry | Drug Compounding - methods | Chitosan - administration & dosage | Antineoplastic Agents, Phytogenic - chemistry | Lipids - administration & dosage | Mice, SCID | Chemistry, Pharmaceutical | Polyethylene Glycols - administration & dosage | Particle Size | Animals | Chitosan - chemistry | Polyglycolic Acid - chemistry | Cell Line, Tumor | Folic Acid - metabolism | Polymers - chemistry | Mice | Nanoparticles - administration & dosage | HeLa Cells | Drug Delivery Systems - methods | Drugs | Phosphates | Drug delivery systems | Leukemia | Liquid chromatography | Permeability | Chromatography | Folic acid | Vehicles | Nanoparticles | Lysine | Fluorescein | Dimethyl sulfoxide | Lymphomas
Journal Article
Diabetes Care, ISSN 0149-5992, 02/2012, Volume 35, Issue 2, pp. 252 - 258
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2012, Volume 158, Issue 3, pp. 470 - 478
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 02/2012, Volume 158, Issue 1, pp. 108 - 114
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2017, Volume 245, pp. 81 - 94
Development of an effective treatment against advanced tumors remains a major challenge for cancer immunotherapy. We have previously developed a potent... 
Peptide vaccine | Tumor microenvironment | Sunitinib base | Advanced melanoma | Polymeric micelles | CANCER-IMMUNOTHERAPY | COMBINATION | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | BREAST-CANCER | NANOPARTICLES | CO-DELIVERY | CISPLATIN | IMMUNE SUPPRESSION | GROWTH | CELL CARCINOMA PATIENTS | PHARMACOLOGY & PHARMACY | Polymers - administration & dosage | Oligodeoxyribonucleotides - administration & dosage | Calcium Phosphates - therapeutic use | Oligodeoxyribonucleotides - chemistry | Immunotherapy, Active | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Membrane Proteins - therapeutic use | Indoles - administration & dosage | Polymers - therapeutic use | Cancer Vaccines - therapeutic use | Pyrroles - administration & dosage | Micelles | Female | Proto-Oncogene Proteins c-akt - metabolism | Pyrroles - therapeutic use | STAT3 Transcription Factor - metabolism | Cytokines - immunology | Oligodeoxyribonucleotides - therapeutic use | Melanoma - metabolism | Tumor Microenvironment - drug effects | Cell Survival - drug effects | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | Peptide Fragments - administration & dosage | Calcium Phosphates - chemistry | Melanoma - pathology | Antineoplastic Agents - chemistry | Membrane Proteins - administration & dosage | Peptide Fragments - chemistry | Animals | Membrane Proteins - chemistry | Tumor Burden - drug effects | Melanoma - immunology | Calcium Phosphates - administration & dosage | Cell Line, Tumor | Pyrroles - chemistry | Indoles - therapeutic use | Polymers - chemistry | Peptide Fragments - therapeutic use | Melanoma - therapy | Indoles - chemistry | Tyrosine | Care and treatment | Analysis | Immunotherapy | Melanoma | Calcium phosphate | Vaccines | T cells | Tumors | Cancer | Advanced Melanoma
Journal Article
Journal of Nephrology, ISSN 1121-8428, 12/2014, Volume 27, Issue 6, pp. 659 - 666
The novel iron-based phosphate binder sucroferric oxyhydroxide is being investigated for the treatment of hyperphosphatemia. Patients with chronic kidney... 
Nephrology | Phase I | Medicine & Public Health | Urology/Andrology | Hyperphosphatemia | Chronic kidney disease | Pharmacokinetics | Sucroferric oxyhydroxide | MORTALITY | PHOSPHORUS | PHOSPHATE BINDER | BIOAVAILABILITY | INDIVIDUALS | DIALYSIS PATIENTS | PA21 | CALCIUM | UROLOGY & NEPHROLOGY | HEMODIALYSIS | CHRONIC KIDNEY-DISEASE | Digoxin - adverse effects | Diuretics - pharmacokinetics | Chelating Agents - administration & dosage | Humans | Middle Aged | Half-Life | Male | Metabolic Clearance Rate | Angiotensin II Type 1 Receptor Blockers - pharmacokinetics | Warfarin - administration & dosage | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Cardiotonic Agents - adverse effects | Diuretics - blood | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Diuretics - administration & dosage | Risk Assessment | Furosemide - pharmacokinetics | Cardiotonic Agents - pharmacokinetics | Omeprazole - administration & dosage | Sucrose - adverse effects | Anticoagulants - adverse effects | Anticoagulants - blood | Cardiotonic Agents - administration & dosage | Models, Biological | Ferric Compounds - adverse effects | Losartan - administration & dosage | Diuretics - adverse effects | Furosemide - administration & dosage | Angiotensin II Type 1 Receptor Blockers - adverse effects | Anticoagulants - administration & dosage | Area Under Curve | Losartan - blood | Omeprazole - blood | Warfarin - adverse effects | Ferric Compounds - administration & dosage | Healthy Volunteers | Furosemide - adverse effects | Adult | Female | Proton Pump Inhibitors - blood | Digoxin - blood | Losartan - pharmacokinetics | Chelating Agents - adverse effects | Furosemide - blood | Sucrose - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Models, Statistical | Digoxin - pharmacokinetics | Warfarin - pharmacokinetics | Proton Pump Inhibitors - pharmacokinetics | Digoxin - administration & dosage | Cardiotonic Agents - blood | Warfarin - blood | Losartan - adverse effects | Anticoagulants - pharmacokinetics | Angiotensin II Type 1 Receptor Blockers - blood | Drug Combinations | Original
Journal Article